Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis (Q44140053)

30 November 2017

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis (English)

1 reference

30 November 2017

1 reference

1 reference

6

Noriaki Sakuragi

1 reference

30 November 2017

4

Hidemichi Watari

1 reference

30 November 2017

1

Yukiharu Todo

1 reference

30 November 2017

2

Hidenori Kato

1 reference

30 November 2017

3

Masanori Kaneuchi

1 reference

30 November 2017

5

Mahito Takeda

1 reference

PubMed ID

20188410

30 November 2017

language of work or name

English

0 references

publication date

24 February 2010

1 reference

30 November 2017

1 reference

30 November 2017

375

1 reference

30 November 2017

1165-1172

1 reference

30 November 2017

9721

1 reference

The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Role of complete lymphadenectomy in endometrioid uterine cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Cox multivariate regression models for estimating prognosis of patients with endometrioid adenocarcinoma of the uterine corpus who underwent thorough surgical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Lymphadenectomy for endometrial cancer: is paraaortic lymphadenectomy necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

The role of comprehensive surgical staging in patients with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Sentinel lymph node detection in patients with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962002-X

7 January 2021

10.1016/S0140-6736(09)62002-X

Identifiers

DOI

1 reference

PubMed ID

20188410

OpenCitations bibliographic resource ID

30 November 2017

0 references

1 reference

PubMed ID

20188410